LET 2.5 (Letrozole 2.5 mg)

This pill with imprint "LET 2.5" is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Dr. Reddy's Laboratories Limited .

Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Letrozole

Imprint:

LET 2.5

Strength:

2.5 mg

Color:

Yellow

Shape:

Round

Availability:

Prescription only

Drug Class:

Aromatase inhibitors
Hormones/antineoplastics

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Dr. Reddy's Laboratories Limited

Inactive Ingredients:

silicon dioxide colloidal
croscarmellose sodium
hypromelloses
lactose monohydrate
magnesium stearate
polyethylene glycol
povidone
magnesium silicate
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.